Dudley Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Hold
1,452
0.7% 36
2026
Q1
$1.34M Sell
1,452
-23
-2% -$23.3K 0.59% 45
2025
Q4
$1.59M Buy
1,475
+10
+0.7% +$9.56K 0.69% 37
2025
Q3
$1.12M Buy
1,465
+20
+1% +$14.9K 0.5% 47
2025
Q2
$1.13M Sell
1,445
-21
-1% -$16.3K 0.56% 44
2025
Q1
$1.21M Sell
1,466
-46
-3% -$38.3K 0.63% 44
2024
Q4
$1.17M Sell
1,512
-32
-2% -$26.5K 0.59% 44
2024
Q3
$1.37M Buy
1,544
+351
+29% +$316K 0.71% 40
2024
Q2
$1.08M Buy
1,193
+288
+32% +$230K 0.6% 48
2024
Q1
$688K Buy
905
+175
+24% +$125K 0.4% 62
2023
Q4
$426K Hold
730
0.27% 75
2023
Q3
$392K Sell
730
-100
-12% -$51.5K 0.28% 70
2023
Q2
$389K Sell
830
-49
-6% -$20.5K 0.26% 73
2023
Q1
$302K Hold
879
0.21% 90
2022
Q4
$322K Buy
+879
New +$312K 0.23% 87

Other funds holding LLY

Dudley Capital Management's LLY Position: Q2 2026 in Review

Dudley Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 1,452 shares worth $1.74M. The position accounts for 0.7% of the portfolio, ranked #36.

Dudley Capital Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dudley Capital Management held 1,452 shares of Eli Lilly worth $1.74M as of Q2 2026.
  • Dudley Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.7% of Dudley Capital Management's portfolio in Q2 2026, its #36 holding.
  • Dudley Capital Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.